| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915960 | Nuclear Medicine and Biology | 2015 | 8 Pages |
Abstract
The high radiochemical purity achieved, and the similar in vivo profile observed for both radioconjugates, make them potential candidates for radiopharmaceuticals for tumor imaging. Further investigations of binding affinity, and uptake of GX1 and RGD-GX1 peptides in tumor models, are warranted.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
E.A. Oliveira, B.L. Faintuch,